IL1B and serum lipopolysaccharide activity: Intravenous administration of either TNF-α or IL-1β can induce a similar change to that caused by endotoxemia and endotoxic shock [29,30], and cardiovascular abnormalities, and mortality can be ameliorated by applying IL-1β receptor antagonist or anti-TNF-α antibodies [31,32].